Keynote Lecture: 

Christina Woo, PhD

Associate Professor, Department of Chemistry & Chemical Biology @ Harvard University

Chemical Approaches to Edit Post-translational Modifications in Cells

Keynote Lecture: 

Nicholas Meanwell, PhD

The Baruch Blumberg Institute, (formerly Vice President, Head of Discovery Chemistry Platforms @ Bristol-Myers Squibb)

The Invention of Fipravirimat, An Inhibitor of HIV-1 Maturation

Amit Choudhary, PhD

Scientific Founder @ Photys Therapeutics

Assistant Professor of Medicine @
Harvard Medical School 
Brigham and Women's Hospital
Broad Institute of MIT and Harvard

Protein Editing Using Small Molecules

Michelle Garnsey, PhD

Senior Principal Scientist @ Pfizer

Discovery of the MC4R Antagonist PF-07258669 as Potential Treatment for Appetite Loss

Mitch Keylor, PhD

Associate Principal Scientist @ Merck

Discovery and Preclinical Characterization of Brain-penetrant, Orally Bioavailable LRRK2 Inhibitors for Parkinson's Disease

Matthew Mitcheltree, PhD

Associate Principal Scientist @ Merck

Engineering Permeability Beyond the Rule of Five: A Case Study in KRAS-Targeting Peptides 

Lewis Pennington, PhD

Head of Platform Chemistry @ Kymera Therapeutics

Holistic Drug Design for Small Molecule Drug Discovery

Nicholas Perl, PhD

Director, Medicinal Chemistry @ Ribon Therapeutics

From Platform to Clinic: Leveraging a MonoART-Focused Chemical Library to Advance PARP7 and PARP14 Inhibitors as Novel Therapeutics

Justin Rettenmaier, PhD

Senior Director, Head of Early Discovery @ Jnana Therapeutics 

RAPID - A Next-Generation Chemoproteomics Technology Enabling the Discovery of Reversible Binders to Pre-specified Targets in Living Cells